Entera Bio ENTX
NASDAQ ENTX
$2.89 -0.02 (-0.69%)
At close: Oct 1, 2026 · 4:00 PM EDT

Entera Bio (ENTX) Accumulated Expenses (2017 - 2026)

Updated

Entera Bio's Accumulated Expenses was $1.33 million in Q2 2026, up 5.0% from $1.27 million a year earlier and up 19.1% from the prior quarter.

Analysis

Entera Bio (ENTX) Accumulated Expenses (2017 - 2026) Analysis & Trends

At the end of FY2025, Accumulated Expenses at Entera Bio came in at $1.53 million, up 74.5% from FY2024.

  • Accumulated Expenses shows a five-year compound annual growth rate of 2.8% (FY2020 to FY2025).
  • In earlier years, Accumulated Expenses was $874,000 in FY2024 (unchanged), $874,000 in FY2023 (-29.1%), $1.23 million in FY2022 (-56.0%) and $2.8 million in FY2021 (+110.6%).
  • Quarterly Accumulated Expenses has moved between $651,000 (Q3 2022) and $2.8 million (Q4 2021) over five years.
  • Compared with a year earlier, Accumulated Expenses was higher in five of the last eight quarters, with growth averaging 17.6%.
  • The best year-over-year quarter for Accumulated Expenses over five years was Q4 2021 (growth of 110.6%); the worst was Q4 2022 (a decline of 56.0%).
  • Per Business Quant data, ENTX's Accumulated Expenses in the three quarters before Q2 2026 was $1.12 million (Q1 2026), $1.53 million (Q4 2025) and $1.19 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Entera Bio 143.43 Mn 112.31 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.33 Mn
Mar 31, 2026 1.12 Mn
Dec 31, 2025 1.53 Mn
Sep 30, 2025 1.19 Mn
Jun 30, 2025 1.27 Mn
Mar 31, 2025 1.32 Mn
Dec 31, 2024 874,000.00
Sep 30, 2024 765,000.00
Jun 30, 2024 1.07 Mn
Mar 31, 2024 902,000.00
Dec 31, 2023 874,000.00
Sep 30, 2023 1.33 Mn
Jun 30, 2023 1.49 Mn
Mar 31, 2023 1.30 Mn
Dec 31, 2022 1.23 Mn
Sep 30, 2022 651,000.00
Jun 30, 2022 1.41 Mn
Mar 31, 2022 1.99 Mn
Dec 31, 2021 2.80 Mn
Dec 31, 2020 1.33 Mn
API Access

Entera Bio Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ENTX&period=max&api_key=YOUR_API_KEY